We are live on ! Find out more
GCM

Ghisallo Capital Management Portfolio holdings

AUM $3.63B
1-Year Est. Return 30.51%
This Fund
S&P 500
This Quarter Est. Return
-4.61%
1 Year Est. Return
+30.51%
3 Year Est. Return
+102.79%
5 Year Est. Return
+106.47%
10 Year Est. Return
–
AUM
$979M
AUM Growth
+$141M
Cap. Flow
+$200M
Cap. Flow %
20.42%
Top 10 Hldgs %
51.65%
Holding
173
New
54
Increased
7
Reduced
11
Closed
58

Top Buys

Rank Stock Value
1
ROL icon
Rollins
ROL
+$101M
2
ARM icon
Arm
ARM
+$66.4M
3
ENB icon
Enbridge
ENB
+$63M
4
AER icon
AerCap
AER
+$46.2M
5
CG icon
Carlyle Group
CG
+$20.9M

Top Sells

Rank Stock Value
1
RNR icon
RenaissanceRe
RNR
+$19.2M
2
AGL icon
Agilon Health
AGL
+$17.3M
3
EG icon
Everest Group
EG
+$17.1M
4
COR icon
Cencora
COR
+$16.4M
5
CCC
CCC Intelligent Solutions
CCC
+$15.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.51%
2 Technology 18.14%
3 Energy 14.52%
4 Industrials 14.19%
5 Financials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DH icon
101
Definitive Healthcare
DH
$73.7M
$400K 0.04%
50,000
– –
CRBU icon
102
Caribou Biosciences
CRBU
$165M
$359K 0.04%
+75,000
New +$465K
LAW icon
103
CS Disco
LAW
$271M
$332K 0.03%
50,000
– –
TMCI icon
104
Treace Medical Concepts
TMCI
$303M
$328K 0.03%
25,000
– –
FDMT icon
105
4D Molecular Therapeutics
FDMT
$582M
$318K 0.03%
25,000
– –
DRVN icon
106
Driven Brands
DRVN
$2.07B
$315K 0.03%
25,000
– –
BMEA icon
107
Biomea Fusion
BMEA
$92.1M
$275K 0.03%
20,000
– –
PACB icon
108
Pacific Biosciences
PACB
$357M
$209K 0.02%
25,000
– –
HLVX
109
DELISTED
HilleVax
HLVX
$202K 0.02%
+15,000
New +$211K
FNA
110
DELISTED
Paragon 28, Inc.
FNA
$188K 0.02%
15,000
– –
NMRA icon
111
Neumora Therapeutics
NMRA
$300M
$141K 0.01%
+10,000
New +$125K
GERN icon
112
Geron
GERN
$949M
$106K 0.01%
50,000
– –
PL icon
113
Planet Labs
PL
$8.23B
$104K 0.01%
40,000
– –
MLYS icon
114
Mineralys Therapeutics
MLYS
$2.41B
$95.1K 0.01%
10,000
– –
SVIIR
115
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
$41.4K ﹤0.01%
211,791
– –
AACT.U
116
DELISTED
Ares Acquisition Corp II Units
AACT.U
– –
-500,000
Closed -$5.14M
AGL icon
117
Agilon Health
AGL
$1.63B
– –
-40,000
Closed -$17.3M
ASTS icon
118
AST SpaceMobile
ASTS
$20.5B
– –
-1,979,653
Closed -$9.3M
ATEC icon
119
Alphatec Holdings
ATEC
$1.47B
– –
-100,000
Closed -$1.8M
ATS icon
120
ATS Corp
ATS
$1.91B
– –
-26,869
Closed -$1.24M
AZEK
121
DELISTED
The AZEK Co
AZEK
– –
-100,000
Closed -$3.03M
BBIO icon
122
BridgeBio Pharma
BBIO
$16.6B
– –
-205,000
Closed -$3.53M
BITO icon
123
ProShares Bitcoin Strategy ETF
BITO
$1.44B
– –
-30,500
Closed -$518K
BLUE
124
DELISTED
bluebird bio
BLUE
– –
-5,000
Closed -$329K
CCC
125
CCC Intelligent Solutions
CCC
$4.11B
– –
-1,389,686
Closed -$15.6M
3 4
5
6 7

Similar funds

VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
ACM
Advent Capital Management New York $3.63B AUM 0.29% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
AA
Advisory Alpha Holland, Michigan $3.66B AUM 14.99% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
MTIM
Marathon Trading Investment Management Radnor, Pennsylvania $3.67B AUM 21.97% 1-Year Est. Return

Ghisallo Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Ghisallo Capital Management held 173 positions worth $979M, up 17% from $838M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Ghisallo Capital Management deployed $200M of net new capital in Q3 2023, opening 54 new positions and adding to 7 existing holdings. Its largest new stake was Rollins: 2,500,000 shares worth $93.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 15% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was RenaissanceRe, an estimated $19.2M trimmed.

  • Ghisallo Capital Management's largest Q3 2023 buy was Rollins: 2,500,000 shares worth $93.3M.
  • Ghisallo Capital Management added most to AerCap in Q3 2023, an estimated $46.2M increase.
  • Ghisallo Capital Management's biggest Q3 2023 reduction was RenaissanceRe, cutting an estimated $19.2M.
  • Ghisallo Capital Management fully exited Agilon Health in Q3 2023, selling an estimated $17.3M.
  • Ghisallo Capital Management's ten largest holdings make up 52% of its $979M portfolio in Q3 2023.
  • Ghisallo Capital Management opened 54 new positions and closed 58 in Q3 2023.
  • Ghisallo Capital Management's portfolio value rose 17% quarter-over-quarter to $979M.

Based on Ghisallo Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.